ADVFN Logo ADVFN

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
22.922,65
-0,79%
S&P 500
5.729,42
-0,82%
Dow Jones
42.542,00
-0,11%
Euro vs US Dollar
1,07822
-0,04%
Bitcoin
86.813,27
-0,75%
Pepperstone
Advertisement
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. Monopar Therapeutics Inc (MNPR) Börsenkurse

Monopar Therapeutics Inc

Monopar Therapeutics Inc (MNPR)

NASDAQ
38,0034
0,4234
( 1,13% )
Aktualisiert: 16:49:22
Verzögert um 15 Minuten
Fortg. Diagramm

Professionelle Tools für Privatanleger.

Premium

Wichtige Statistiken und Details

Current Price
38,0034
Gebot
37,40
Fragen
37,99
Volumen
4.156
37,50 Tagesbereich 38,0034
1,719 52-Wochen-Bereich 54,30
Marktkapitalisierung
200,574M
Handelsende
37,58
Handelsbeginn
37,99
Letzte Trade
1
@
37.1538
Letzter Handelszeitpunkt
16:49:55
Finanzvolumen
US$ 157.916
VWAP
37,997
Durchschnittliches Volumen (3 Mio.)
51.594
Ausgegebene Aktien
5.277.796
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-23,87
Gewinn pro Aktie (EPS)
-1,59
Erlöse
-
Nettogewinn
-8,4M

Über Monopar Therapeutics Inc

Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of?Validive?for the prevention of chemoradiotherapy-induced severe oral mu... Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of?Validive?for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicin?for the treatment?of advanced soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for advanced cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
www.monopartx.com
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Monopar Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker MNPR. The last closing price for Monopar Therapeutics was US$37,58. Over the last year, Monopar Therapeutics shares have traded in a share price range of US$ 1,719 to US$ 54,30.

Monopar Therapeutics currently has 5.277.796 shares in issue. The market capitalisation of Monopar Therapeutics is US$198,34 million. Monopar Therapeutics has a price to earnings ratio (PE ratio) of -23.87.

MNPR Neueste Nachrichten

Weitere Nachrichten

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
08 März 2025
MNPR (1,13%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
08 März 2025
MNPR (1,13%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
08 März 2025
MNPR (1,13%)

Form 3 - Initial statement of beneficial ownership of securities
Edgar (US Regulatory)
07 März 2025
MNPR (1,13%)

Form 8-K - Current report
Edgar (US Regulatory)
03 März 2025
MNPR (1,13%)

Form 8-K - Current report
Edgar (US Regulatory)
24 Februar 2025
MNPR (1,13%)

Form EFFECT - Notice of Effectiveness
Edgar (US Regulatory)
28 Januar 2025
MNPR (1,13%)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
11.44343.9480306345736.5647.8252343844740.47052841CS
46.603421.029936305731.447.825227.053416633.71622753CS
1215.403468.156637168122.654.3215159437.45065488CS
2632.5634598.5919117655.4454.34.531402425.78139119CS
5234.60341017.747058823.454.31.71937369612.88163153CS
15625.5034204.027212.554.31.36957165986.16424539CS
2603.753410.958832116834.2585.051.36954587848.35129025CS

MNPR - Frequently Asked Questions (FAQ)

What is the current Monopar Therapeutics share price?
The current share price of Monopar Therapeutics is US$ 38,0034
How many Monopar Therapeutics shares are in issue?
Monopar Therapeutics has 5.277.796 shares in issue
What is the market cap of Monopar Therapeutics?
The market capitalisation of Monopar Therapeutics is USD 198,34M
What is the 1 year trading range for Monopar Therapeutics share price?
Monopar Therapeutics has traded in the range of US$ 1,719 to US$ 54,30 during the past year
What is the PE ratio of Monopar Therapeutics?
The price to earnings ratio of Monopar Therapeutics is -23,87
What is the reporting currency for Monopar Therapeutics?
Monopar Therapeutics reports financial results in USD
What is the latest annual profit for Monopar Therapeutics?
The latest annual profit of Monopar Therapeutics is USD -8,4M
What is the registered address of Monopar Therapeutics?
The registered address for Monopar Therapeutics is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Monopar Therapeutics website address?
The website address for Monopar Therapeutics is www.monopartx.com
Which industry sector does Monopar Therapeutics operate in?
Monopar Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
PTPIPetros Pharmaceuticals Inc
US$ 0,209
(261,59%)
986,42M
OSRHOSR Holdings Inc
US$ 3,2989
(106,18%)
62,4M
VVPRVivoPower International PLC
US$ 3,9308
(73,93%)
117,52M
SURGSurgePays Inc
US$ 2,3477
(70,12%)
57,52M
ULYUrgent ly Inc
US$ 5,6848
(45,39%)
353,52k
BACKIMAC Holdings Inc
US$ 0,081
(-59,50%)
929,01k
ACRVAcrivon Therapeutics Inc
US$ 3,3879
(-37,14%)
758,06k
TNONTenon Medical Inc
US$ 2,54
(-32,27%)
15,26M
HUMAHumacyte Inc
US$ 2,0399
(-29,05%)
13,94M
ICGIntchains Group Ltd
US$ 3,00
(-27,18%)
101,6k
PTPIPetros Pharmaceuticals Inc
US$ 0,209
(261,59%)
986,42M
OCEAOcean Biomedical Inc
US$ 0,0794
(39,79%)
230,82M
LYTLytus Technologies Holdings PTV Ltd
US$ 0,0627
(23,91%)
141,54M
NVDANVIDIA Corporation
US$ 114,895
(-4,80%)
129,19M
VVPRVivoPower International PLC
US$ 3,9308
(73,93%)
117,52M

MNPR Finanzen

Finanzen

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
MNPR
Monopar Therapeutics
NASDAQ
FOLD
Amicus Therapeutics
USOTC
ASDZF
Arctic Star Exploration (PK)
NYSE
ISEP
Innovator ETFs T
NASDAQ
ASPA
ABRI SPAC I
NASDAQ
OPTN
OptiNose
USOTC
AGRPY
Absa (PK)
USOTC
ADRLF
Adavale Resources (PK)
AQSE
TE21
Test Stock 21
Delayed Upgrade Clock
ADVFN Logo
Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten

Werbung entfernen

Melden Sie sich für ein werbefreies Erlebnis an

Keine Werbung

Versuchen Sie es jetzt

Anzeigen behalten